Nicotinic acetylcholine receptors mediate lung cancer growth

Frontiers in Physiology

Volumn 4 SEP, Issue , 2013, Pages

  Reina Improgo, Ma ^a,b   Soll, Lindsey G ^a   Tapper, Andrew R ^a   Gardner, Paul D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CHRNA5; Ligand gated ion channel; Lung cancer; Nicotinic acetylcholine receptor; Small cell lung carcinoma

Indexed keywords

ALPHA CONOTOXIN AUIB; CONOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; NICOTINIC RECEPTOR; PROTEIN BCL 2; PROTEIN KINASE B; RAF PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHRNA3 GENE; CHRNA5 GENE; CHRNB4 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; NONHUMAN; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; TOBACCO DEPENDENCE; TUMOR VOLUME;

EID: 84884563035     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00251     Document Type: Article

References (60)

1. Albuquerque, E. X., Pereira, E. F., Alkondon, M., and Rogers, S. W. (2009). Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89, 73-120. doi: 10.1152/physrev.00015.2008
2. Al-Wadei, H. A., Al-Wadei, M. H., Ullah, M. F., and Schuller, H. M. (2012). Gamma-amino butyric acid inhibits the nicotine-imposed stimulatory challenge in xenograft models of non-small cell lung carcinoma. Curr. Cancer Drug Targets 12, 97-106. doi: 10.2174/156800912799095171
3. Amos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., et al. (2008). Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616-622. doi: 10.1038/ng.109
4. Azam, L., and McIntosh, J. M. (2009). Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta Pharmacol. Sin. 30, 771-783. doi: 10.1038/aps.2009.47
5. Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X., et al. (2008). Variants in nicotinic receptors and risk for nicotine dependence. Am. J. Psychiatry 165, 1163-1171. doi: 10.1176/appi.ajp.2008.07111711
6. Boulter, J., O'Shea-Greenfield, A., Duvoisin, R. M., Connolly, J. G., Wada, E., Jensen, A., et al. (1990). Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J. Biol. Chem. 265, 4472-4482.
7. Calleja-Macias, I. E., Kalantari, M., and Bernard, H. U. (2009). Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis? Int. J. Cancer 124, 1090-1096. doi: 10.1002/ijc.24053
8. Chernyavsky, A. I., Arredondo, J., Galitovskiy, V., Qian, J., and Grando, S. A. (2009). Structure and function of the nicotinic arm of acetylcholine regulatory axis in human leukemic T cells. Int. J. Immunopathol. Pharmacol. 22, 461-472.
9. Codignola, A., Tarroni, P., Cattaneo, M. G., Vicentini, L. M., Clementi, F., and Sher, E. (1994). Serotonin release and cell proliferation are under the control of alphabungarotoxin- sensitive nicotinic receptors in small-cell lung carcinoma cell lines. FEBS Lett. 342, 286-290. doi: 10.1016/0014-5793(94)80518-0
10. Conklin, B. S., Zhao, W., Zhong, D. S., and Chen, C. (2002). Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am. J. Pathol. 160, 413-418. doi: 10.1016/S0002-9440(10)64859-6
11. Damaj, M. I., Kao, W., and Martin, B. R. (2003). Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J. Pharmacol. Exp. Ther. 307, 526-534. doi: 10.1124/jpet.103.054908
12. Davis, R., Rizwani, W., Banerjee, S., Kovacs, M., Haura, E., Coppola, D., et al. (2009). Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS ONE 4, e7524. doi: 10.1371/journal.pone.0007524
13. Falvella, F. S., Galvan, A., Frullanti, E., Spinola, M., Calabro, E., Carbone, A., et al. (2009). Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk. Clin. Cancer Res. 15, 1837-1842. doi: 10.1158/1078-0432.CCR-08-2107
14. Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., and Kenny, P. J. (2011). Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471, 597-601. doi: 10.1038/nature09797
15. Frahm, S., Slimak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes, B., Auer, S., et al. (2011). Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula. Neuron 70, 522-535. doi: 10.1016/j.neuron.2011.04.013
16. George, A. A., Lucero, L. M., Damaj, M. I., Lukas, R. J., Chen, X., and Whiteaker, P. (2012). Function of human alpha3beta4alpha5 nicotinic acetylcholine receptors is reduced by the alpha5(D398N) variant. J. Biol. Chem. 287, 25151-25162. doi: 10.1074/jbc. M112.379339
17. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. doi: 10.1016/S0092-8674(00)81683-9
18. Hecht, S. S. (1999). Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91, 1194-1210. doi: 10.1093/jnci/91.14.1194
19. Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., et al. (2001). Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 7, 833-839. doi: 10.1038/89961
20. Heeschen, C., Weis, M., Aicher, A., Dimmeler, S., and Cooke, J. P. (2002). A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J. Clin. Invest. 110, 527-536. doi: 10.1172/JCI200214676
21. Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., et al. (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633-637. doi: 10.1038/nature06885
22. Improgo, M. R., Johnson, C. W., Tapper, A. R., and Gardner, P. D. (2011). Bioluminescence-based high-throughput screen identifies pharmacological agents that target neurotransmitter signaling in small cell lung carcinoma. PLoS ONE 6, e24132. doi: 10.1371/journal.pone.0024132
23. Improgo, M. R., Schlichting, N. A., Cortes, R. Y., Zhao-Shea, R., Tapper, A. R., and Gardner, P. D. (2010). ASCL1 regulates the expression of the CHRNA5/A3/B4 lung cancer susceptibility locus. Mol. Cancer Res. 8, 194-203. doi: 10.1158/1541-7786.MCR-09-0185
24. Jin, Z., Gao, F., Flagg, T., and Deng, X. (2004a). Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J. Biol. Chem. 279, 23837-23844. doi: 10.1074/jbc. M402566200
25. Jin, Z., Gao, F., Flagg, T., and Deng, X. (2004b). Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J. Biol. Chem. 279, 40209-40219. doi: 10.1074/jbc. M404056200
26. Jull, B. A., Plummer, H. K. 3rd., and Schuller, H. M. (2001). Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J. Cancer Res. Clin. Oncol. 127, 707-717.
27. Lam, D. C., Girard, L., Ramirez, R., Chau, W. S., Suen, W. S., Sheridan, S., et al. (2007). Expression of nicotinic acetylcholine receptor subunit genes in non-smallcell lung cancer reveals differences between smokers and nonsmokers. Cancer Res. 67, 4638-4647. doi: 10.1158/0008-5472.CAN-06-4628
28. Le Marchand, L., Derby, K. S., Murphy, S. E., Hecht, S. S., Hatsukami, D., Carmella, S. G., et al. (2008). Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res. 68, 9137-9140. doi: 10.1158/0008-5472.CAN-08-2271
29. Le Novere, N., Corringer, P. J., and Changeux, J. P. (2002). The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J. Neurobiol. 53, 447-456. doi: 10.1002/neu.10153
30. Lukas, R. J. (1993). Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line. J. Pharmacol. Exp. Ther. 265, 294-302.
31. Luo, S., Kulak, J. M., Cartier, G. E., Jacobsen, R. B., Yoshikami, D., Olivera, B. M., et al. (1998). alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18, 8571-8579.
32. Maglott, D., Ostell, J., Pruitt, K. D., and Tatusova, T. (2011). Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 39, D52-D57. doi: 10.1093/nar/gkq1237
33. Maneckjee, R., and Minna, J. D. (1990). Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. 87, 3294-3298. doi: 10.1073/pnas.87.9.3294
34. Maneckjee, R., and Minna, J. D. (1994). Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ. 5, 1033-1040.
35. Paradiso, K. G., and Steinbach, J. H. (2003). Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors. J. Physiol. 553, 857-871. doi: 10.1113/jphysiol.2003.053447
36. Proskocil, B. J., Sekhon, H. S., Jia, Y., Savchenko, V., Blakely, R. D., Lindstrom, J., et al. (2004). Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 145, 2498-2506. doi: 10.1210/en.2003-1728
37. Ramirez-Latorre, J., Yu, C. R., Qu, X., Perin, F., Karlin, A., and Role, L. (1996). Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature 380, 347-351. doi: 10.1038/380347a0
38. Rom, W. N., Hay, J. G., Lee, T. C., Jiang, Y., and Tchou-Wong, K. M. (2000). Molecular and genetic aspects of lung cancer. Am. J. Respir. Crit. Care Med. 161, 1355-1367. doi: 10.1164/ajrccm.161.4.9908012
39. Rose, J. E. (2007). Multiple brain pathways and receptors underlying tobacco addiction. Biochem. Pharmacol. 74, 1263-1270. doi: 10.1016/j.bcp.2007.07.039
40. Rudin, C. M., Hann, C. L., Peacock, C. D., and Watkins, D. N. (2008). Novel systemic therapies for small cell lung cancer. J. Natl. Compr. Canc. Netw. 6, 315-322.
41. Salas, R., Cook, K. D., Bassetto, L., and De Biasi, M. (2004). The α3 and β4 nicotinic receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47, 401-407. doi: 10.1016/j.neuropharm.2004.05.002
42. Salas, R., Sturm, R., Boulter, J., and De Biasi, M. (2009). Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J. Neurosci. 29, 3014-3018. doi: 10.1523/JNEUROSCI.4934-08.2009
43. Sandler, A. B. (2003). Chemotherapy for small cell lung cancer. Semin. Oncol. 30, 9-25. doi: 10.1053/sonc.2003.50012
44. Sato, K. Z., Fujii, T., Watanabe, Y., Yamada, S., Ando, T., Kazuko, F., et al. (1999). Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci. Lett. 266, 17-20. doi: 10.1016/S0304-3940 (99)00259-1
45. Schuller, H. M. (1989). Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem. Pharmacol. 38, 3439-3442. doi: 10.1016/0006-2952(89)90112-3
46. Schuller, H. M. (2007). Nitrosamines as nicotinic receptor ligands. Life Sci. 80, 2274-2280. doi: 10.1016/j.lfs.2007.03.006
47. Schuller, H. M. (2009). Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat. Rev. Cancer 9, 195-205. doi: 10.1038/nrc2590
48. Schuller, H. M., and Orloff, M. (1998). Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem. Pharmacol. 55, 1377-1384. doi: 10.1016/S0006-2952(97)00651-5
49. Scofield, M. D., Bruschweiler-Li, L., Mou, Z., and Gardner, P. D. (2008). Transcription factor assembly on the nicotinic receptor beta4 subunit gene promoter. Neuroreport 19, 687-690. doi: 10.1097/WNR.0b013e3282fbcef7
50. Siegel, H. N., and Lukas, R. J. (1988). Nicotinic agonists regulate alpha-bungarotoxin binding sites of TE671 human medulloblastoma cells. J. Neurochem. 50, 1272-1278. doi: 10.1111/j.1471-4159.1988.tb10604.x
51. Song, P., Sekhon, H. S., Jia, Y., Keller, J. A., Blusztajn, J. K., Mark, G. P., et al. (2003). Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 63, 214-221.
52. Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., et al. (2008). A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638-642. doi: 10.1038/nature06846
53. Trombino, S., Cesario, A., Margaritora, S., Granone, P., Motta, G., Falugi, C., et al. (2004). Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res. 64, 135-145. doi: 10.1158/0008-5472.CAN-03-1672
54. Tsurutani, J., Castillo, S. S., Brognard, J., Granville, C. A., Zhang, C., Gills, J. J., et al. (2005). Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 26, 1182-1195. doi: 10.1093/carcin/bgi072
55. Wang, J. C., Cruchaga, C., Saccone, N. L., Bertelsen, S., Liu, P., Budde, J. P., et al. (2009). Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum. Mol. Genet. 18, 3125-3135. doi: 10.1093/hmg/ddp231
56. West, K. A., Brognard, J., Clark, A. S., Linnoila, I. R., Yang, X., Swain, S. M., et al. (2003). Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J. Clin. Invest. 111, 81-90. doi: 10.1172/JCI200316147
57. WHO. (2011). Cancer Fact Sheet. Geneva: World Health Organization.
58. Ye, Y. N., Liu, E. S., Shin, V. Y., Wu, W. K., and Cho, C. H. (2004). The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. J. Pharmacol. Exp. Ther. 311, 123-130. doi: 10.1124/jpet.104.068031
59. Yu, C. R., and Role, L. W. (1998). Functional contribution of the alpha5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurones. J. Physiol. 509(Pt 3), 667-681. doi: 10.1111/j.1469-7793.1998.667bm.x
60. Zheng, Y., Ritzenthaler, J. D., Roman, J., and Han, S. (2007). Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am. J. Respir. Cell Mol. Biol. 37, 681-690. doi: 10.1165/rcmb.2007-0051O